BioSpace News Archive

Fortress Biotech, Inc. announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in the H.C. Wainwright BioConnect Virtual Conference scheduled to take place from Monday, January 10 through Thursday, January 13, 2022.

Natera, Inc., a leader in personalized genetic testing and diagnostics, announced its expansion into the early cancer detection market to advance the company’s strategic growth objectives in emerging areas of ECD and screening.

Veracyte, Inc . (Nasdaq: VCYT) today announced key leadership promotions that further position the company to achieve its strategic global vision.

Zymeworks to Present at 40th Annual J.P. Morgan Healthcare Conference.

AngioDynamics, Inc. today announced financial results for the second quarter of fiscal year 2022, which ended November 30, 2021.

Humacyte, Inc. (Nasdaq: HUMA), today announced that results from the first series of compassionate use cases of Humacyte’s Human Acellular VesselTM (HAV) will be presented at the 46th Annual Winter Meeting of the Vascular and Endovascular Surgery Society (VESS) in Snowmass, Colo. at 7:56 a.m. MST on January 28, 2022.

Avalo Therapeutics, Inc. today provides a comprehensive update on the Company’s growth opportunities and mid-stage development portfolio.

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced that management will present at the H.C. Wainwright BioConnect 2022 Conference, being held virtually January 10-13, 2022.

Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, announced it will be featured as a presenting company at the H.C. Wainwright Bioconnect Conference.

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and other viral diseases, announced that John McHutchison, AO, MD, chief executive officer and president, will present during the HC Wainwright Virtual BIOCONNECT Conference, January 10-13, 2022.